Cover Image

Effect of human mesenchymal stem cells on hepatoma cell line

Mohamed T. Abdel Aziz, Hanan H. Fouad, Nagwa K. Roshdy, Laila A. Rashed, Dina Sabry, Amira A. Hassouna, Fatma M. Taha, Walaa Ibrahim, Mohamed Mahmoud
  • Mohamed T. Abdel Aziz
    Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt
  • Hanan H. Fouad
    Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt
  • Nagwa K. Roshdy
    Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt | nagwaroshdy@yahoo.com
  • Laila A. Rashed
    Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt
  • Dina Sabry
    Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt
  • Amira A. Hassouna
    Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt
  • Fatma M. Taha
    Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt
  • Walaa Ibrahim
    Department of Medical Biochemistry, Unit of Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt
  • Mohamed Mahmoud
    Department of Tropical Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt

Abstract

Human mesenchymal stem cells (hMSCs) are mostly studied for their potential clinical use. Little is known about the underlying molecular mechanisms that link hMSCs to the targeted inhibition of tumor cells. The present study was conducted to evaluate the tumor suppressive effects of human mesenchymal stem cells (hMSCs) on human hepatoma cell line (HepG2) and their signaling mechanisms. To fulfill this objective, the influence of hMSCs on genes concerned with apoptosis, mitogenesis as well as on the proliferation of HepG2 cell line was investigated using either hMSCs-conditioned or using hMSCs and HepG2 co-culture conditioned media. Cell survival was evaluated using cell proliferation (MTT) assay kit. Gene expression of survivin, proliferating cell nuclear antigen (PCNA), β-Catenin, telomerase and VEGF was assessed by real time reverse transcription-polymerase chain reaction (RT-PCR). HpG2 cells cultured with either hMSCs-conditioned media or with hMSCs&HepG2 co-culture conditioned media showed decreased proliferation and decreased expression of survivin, PCNA, β-Catenin and telomerase. However, both media had increased expression of VEGF. Treatment of HepG2 cells by either hMSCs conditioned media or by hMSCs and HepG2 co-culture condition media led to a significant decrease in cell proliferation and down regulation of genes concerned with antiapoptosis, mitogenesis, and cell proliferation. This indicates that hMSCs can suppress tumorigenesis through factors produced in their conditioned media.

Keywords

mesenchymal stem cells, HepG2 cell line, Survivin, PCNA, β-Catenin, telomerase, VEGF.

Full Text:

PDF
Submitted: 2011-07-09 17:24:55
Published: 2011-09-28 15:08:46
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
616

Views:
PDF
242

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2011 Mohamed T. Abdel Aziz, Hanan H. Fouad, Nagwa K. Roshdy, Laila A. Rashed, Dina Sabry, Amira A. Hassouna, Fatma M. Taha, Walaa Ibrahim, Mohamed Mahmoud

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185